Y. Lin

发表

Altered Gag Polyprotein Cleavage Specificity of Feline Immunodeficiency Virus/Human Immunodeficiency Virus Mutant Proteases as Demonstrated in a Cell-Based Expression System

B. Torbett, Chi‐Huey Wong, A. Brik, 2006, Journal of Virology.

Structural Basis for Distinctions between Substrate and Inhibitor Specificities for Feline Immunodeficiency Virus and Human Immunodeficiency Virus Proteases

Arthur J. Olson, Garrett M. Morris, Zachary Q. Beck, 2003, Journal of Virology.

Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization.

A. Olson, K. Sharpless, V. Fokin, 2006, Journal of medicinal chemistry.

Inhibitors of HIV-1 protease by using in situ click chemistry.

William Lindstrom, Arthur J Olson, John H Elder, 2006, Angewandte Chemie.

Rapid Diversity‐Oriented Synthesis in Microtiter Plates for In Situ Screening of HIV Protease Inhibitors

David S Goodsell, Chi-Huey Wong, Arthur J Olson, 2003, Chembiochem : a European journal of chemical biology.

A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant.

B. Torbett, Chi‐Huey Wong, D. McRee, 2008, Journal of medicinal chemistry.

TRIM22 inhibits respiratory syncytial virus replication by targeting JAK‐STAT1/2 signaling

Renli Zhang, Xiaoping Xiao, Y. Lin, 2020, Journal of medical virology.

A. Olson, V. Fokin, J. Elder, 2006, Journal of medicinal chemistry.

Conformational Studies of Sialyl Lewis-X in Aqueous-Solution

Chi‐Huey Wong, K. Nicolaou, C. W. Hummel, 1992 .

1,2,3‐Triazole as a Peptide Surrogate in the Rapid Synthesis of HIV‐1 Protease Inhibitors

David S Goodsell, Alexander Wlodawer, Chi-Huey Wong, 2005, Chembiochem : a European journal of chemical biology.

Conformational Studies of Sialyl Lewis X in Aqueous Solution.

Chi‐Huey Wong, K. Nicolaou, C. W. Hummel, 1992 .

Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3

B. Torbett, C. Stout, K. Tam, 2007, Retrovirology.

Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV.

C. K. Grant, John H Elder, J. Elder, 2010, Current HIV research.

Molecular mechanisms of FIV infection.

C. K. Grant, J. Elder, A. de Parseval, 2008, Veterinary immunology and immunopathology.

ts1 MoMuLV: A Murine Model of Neuroimmunodegeneration

W. Choe, W. Lynn, Y. Lin, 1998 .

Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3.

G. Morris, B. Torbett, C. Stout, 2006, Journal of molecular biology.

Epoxide opening in water and screening in situ for rapid discovery of enzyme inhibitors in microtiter plates.

Chi‐Huey Wong, A. Brik, J. Elder, 2006, Bioorganic & medicinal chemistry.

Molecular Basis for the Relative Substrate Specificity of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Proteases

Zachary Q. Beck, John H. Elder, Z. Beck, 2001, Journal of Virology.

Viral Evolution in Response to the Broad-Based Retroviral Protease Inhibitor TL-3

Arthur J. Olson, Douglas D. Richman, Garrett Morris, 2001, Journal of Virology.

Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3

S. Henriksen, B. Torbett, D. Sheeter, 2004, Retrovirology.

Conformational flexibility in the flap domains of ligand-free HIV protease.

B. Torbett, D. McRee, R. Rosenfeld, 2007, Acta crystallographica. Section D, Biological crystallography.

Resolution and Prevention of Feline Immunodeficiency Virus-Induced Neurological Deficits by Treatment with the Protease Inhibitor TL-3

S. Henriksen, B. Torbett, D. L. Lerner, 2004, Journal of Virology.

Development of a New Type of Protease Inhibitors, Efficacious against FIV and HIV Variants

Arthur J. Olson, Garrett M. Morris, Van-Duc Le, 1999 .

Chemical‐Enzymatic Synthesis and Conformational Analysis of Sialyl Lewis x and Derivatives.

Chi-Huey Wong, Yoshitaka Ichikawa, James C. Paulson, 1993 .

Small molecule regulation of protein conformation by binding in the Flap of HIV protease.

A. Olson, B. Torbett, C. Stout, 2013, ACS chemical biology.

A quick diversity-oriented amide-forming reaction to optimize P-subsite residues of HIV protease inhibitors.

Chi‐Huey Wong, A. Brik, J. Elder, 2002, Chemistry & biology.

Alteration of Substrate and Inhibitor Specificity of Feline Immunodeficiency Virus Protease

Arthur J. Olson, Garrett M. Morris, Van-Duc Le, 2000, Journal of Virology.

Generation of Infectious Feline Immunodeficiency Virus (FIV) Encoding FIV/Human Immunodeficiency Virus Chimeric Protease

B. Torbett, J. Elder, Y. Lin, 2010, Journal of Virology.

Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries.

Sukwon Hong, Rolf Muller, Dale L Boger, 2010, The Biochemical journal.

Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV protease.

Arthur J Olson, C David Stout, John H Elder, 2011, Acta crystallographica. Section D, Biological crystallography.

Selection of Drug-Resistant Feline Immunodeficiency Virus (FIV) Encoding FIV/HIV Chimeric Protease in the Presence of HIV-Specific Protease Inhibitors

J. Elder, Meaghan Happer, Y. Lin, 2013, Journal of Virology.

Structure-activity studies of FIV and HIV protease inhibitors containing allophenylnorstatine.

C. Wong, C. Mak, J. Elder, 2001, Bioorganic & medicinal chemistry.